Search Results 911-920 of 17737 for corticosteroid

1. A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma - Mayo Clinic

   Treated with medium dose inhaled corticosteroid (ICS), or high dose ICS, or low dose ICS plus long- acting beta agonist (LABA), or low dose ICS plus ...

2. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   have discontinued corticosteroid treatment for these metastases for at least 14 days; and ... systemic corticosteroids at physiologic doses ≤ 10 mg/day of ...

3. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   ... corticosteroids at doses =< 4 mg/day of dexamethasone or equivalent; steroids as premedication for hypersensitivity reactions [e.g., computed tomography (CT) ...

4. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   recovered from the acute effects of radiation therapy or surgery prior to randomization, have discontinued corticosteroid treatment for at least 2 weeks, and ...

5. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

   ... corticosteroids. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

6. A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - Mayo Clinic

   Currently receiving treatment for DLE/SCLE with a stable regimen of at least one of the following medications: oral corticosteroid, and/or antimalarial, and/or ...

7. A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid - Mayo Clinic

   Candidate for systemic corticosteroid therapy. Able to complete PRO ... corticosteroid, or any experimental anti-inflammatory therapy) within 3 ...

8. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

   Participation eligibility · Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the 7 days prior to ...

9. Vaccine Therapy and Resiquimod in Treating Patients with Stage II-IV Melanoma that has been Removed by Surgery - Mayo Clinic

   ... corticosteroids; (use of corticosteroids in doses not exceeding those used for adrenal replacement is acceptable); History of brain metastases (even if ...

10. COVID-19 - 2023 Archives - Mayo Clinic News Network

    Corticosteroids lower the likelihood of in-hospital mortality from COVID-19. Vincent Jacobbi. August 4, 2023. First · 1 · 2 · Next · Last. Explore more topics.